LIPILipidor ABLIPI info
$0.01info-0.78%24h
Global rank
Market cap$333.88K
Change 7d14.48%
YTD Performance-74.90%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Lipidor AB (LIPI) Stock Overview

    Lipidor AB (publ), a pharmaceutical development company, engages in the development of drugs for the treatment of psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis. The company develops AKP-01, which is in Phase III for the treatment of psoriasis; and preclinical stage products, such as AKP-02 for psoriasis, AKP-03 for bacterial skin diseases, and AKP-07 for atopic dermatitis. It offers active pharmaceutical ingredients used in products for various therapeutic applications, such as anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine. The company also develops a range of spray products for animal skin care in dogs, cats, and horses; and consumer health care products for applications, including antibacterial, antiseptic, moisturizing emollient, disinfectant, and acne and wart treatment. It has a collaboration agreement with Cannassure Therapeutics Ltd. for the development of topical medicinal cannabis products for the treatment of skin inflammations and psoriatic lesions. The company was incorporated in 2009 and is based in Danderyd, Sweden.

    LIPI Stock Information

    Symbol
    LIPI
    Address
    Svärdvägen 13Danderyd, 182 33Sweden
    Founded
    -
    Trading hours
    -
    Website
    https://lipidor.se
    Country
    🇸🇪 Sweden
    Phone Number
    46 7 25 07 03 69

    Lipidor AB (LIPI) Price Chart

    -
    Value:-

    Lipidor AB Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.011522311384772332
    N/A
    Market Cap
    $333.88K
    N/A
    Shares Outstanding
    28.98M
    N/A
    Employees
    8.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org